IRIS Accounts Production v26.1.0.640 08067182 Board of Directors 1.10.24 30.9.25 30.9.25 17.4.26 false true false false true false Auditors Opinion iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 08067182 2024-09-30 08067182 2025-09-30 08067182 2024-10-01 2025-09-30 08067182 2023-09-30 08067182 2023-10-01 2024-09-30 08067182 2024-09-30 08067182 ns15:EnglandWales 2024-10-01 2025-09-30 08067182 ns14:PoundSterling 2024-10-01 2025-09-30 08067182 ns10:Director1 2024-10-01 2025-09-30 08067182 ns10:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 08067182 ns10:SmallEntities 2024-10-01 2025-09-30 08067182 ns10:Audited 2024-10-01 2025-09-30 08067182 ns10:SmallCompaniesRegimeForDirectorsReport 2024-10-01 2025-09-30 08067182 ns10:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 08067182 ns10:FullAccounts 2024-10-01 2025-09-30 08067182 ns10:Director2 2024-10-01 2025-09-30 08067182 ns10:Director3 2024-10-01 2025-09-30 08067182 ns10:RegisteredOffice 2024-10-01 2025-09-30 08067182 ns5:CurrentFinancialInstruments 2025-09-30 08067182 ns5:CurrentFinancialInstruments 2024-09-30 08067182 ns5:ShareCapital 2025-09-30 08067182 ns5:ShareCapital 2024-09-30 08067182 ns5:RetainedEarningsAccumulatedLosses 2025-09-30 08067182 ns5:RetainedEarningsAccumulatedLosses 2024-09-30 08067182 ns5:PlantMachinery 2024-10-01 2025-09-30 08067182 ns5:PlantMachinery 2024-09-30 08067182 ns5:PlantMachinery 2025-09-30 08067182 ns5:PlantMachinery 2024-09-30 08067182 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-09-30 08067182 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-09-30 08067182 ns5:WithinOneYear 2025-09-30 08067182 ns5:WithinOneYear 2024-09-30 08067182 ns5:BetweenOneFiveYears 2025-09-30 08067182 ns5:BetweenOneFiveYears 2024-09-30 08067182 ns5:AllPeriods 2025-09-30 08067182 ns5:AllPeriods 2024-09-30

REGISTERED NUMBER: 08067182 (England and Wales)

| FINANCIAL STATEMENTS |

| FOR THE YEAR ENDED 30 SEPTEMBER 2025 |

| FOR |

| EUROPEAN MEDICINES LIMITED |

EUROPEAN MEDICINES LIMITED (REGISTERED NUMBER: 08067182)

CONTENTS OF THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2025

Page |

Company Information | 1 |

Balance Sheet | 2 |

Notes to the Financial Statements | 3 |

EUROPEAN MEDICINES LIMITED

COMPANY INFORMATION

FOR THE YEAR ENDED 30 SEPTEMBER 2025

| DIRECTORS: | R Knight

| C Piket

| P M Sturkenboom

| REGISTERED OFFICE: | 5 Liverpool Terrace

| Worthing

| West Sussex

| BN11 1TA

| REGISTERED NUMBER: | 08067182 (England and Wales)

| SENIOR STATUTORY AUDITOR: | Douglas Paton BSc CA

| AUDITORS: | Bannerman Johnstone Maclay Limited

| Chartered Accountants

| and Statutory Auditor

| 213 St Vincent Street

| Glasgow

| G2 5QY

EUROPEAN MEDICINES LIMITED (REGISTERED NUMBER: 08067182)

BALANCE SHEET

30 SEPTEMBER 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Tangible assets | 4 | 1,779 |  | 2,895 |  |

CURRENT ASSETS

Debtors | 5 | 19,680 |  | 9,957 |  |

Cash at bank | 281,590 |  | 274,007 |  |

301,270 |  | 283,964 |  |

CREDITORS

Amounts falling due within one year | 6 | 40,583 |  | 22,999 |  |

NET CURRENT ASSETS | 260,687 |  | 260,965 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 262,466 |  | 263,860 |  |

CAPITAL AND RESERVES

Called up share capital | 1,000 |  | 1,000 |  |

Retained earnings | 261,466 |  | 262,860 |  |

SHAREHOLDERS' FUNDS | 262,466 |  | 263,860 |  |

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 April 2026 and were signed on its behalf by:

R Knight - Director

EUROPEAN MEDICINES LIMITED (REGISTERED NUMBER: 08067182)

NOTES TO THE FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2025

1. | STATUTORY INFORMATION

| European Medicines Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| Related party exemption

| The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

| Plant and machinery etc | - | 25% on cost

| Financial instruments

| The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

| Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

| Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

| Basic financial assets

| Basic financial assets, which include certain debtors and cash and bank balances, are initially measured at transaction price including transactions costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

| Classification of financial liabilities

| Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

EUROPEAN MEDICINES LIMITED (REGISTERED NUMBER: 08067182)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 SEPTEMBER 2025

2. | ACCOUNTING POLICIES - continued

| Basic financial liabilities

| Basic financial liabilities, including certain creditors and loans from related undertakings, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

| Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

| Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 7 (2024 - 7 ) .

4. | TANGIBLE FIXED ASSETS

| Plant and

| machinery

| etc

£ |

| COST

| At 1 October 2024

| and 30 September 2025 | 28,420 |  |

| DEPRECIATION

| At 1 October 2024 | 25,525 |  |

| Charge for year | 1,116 |  |

| At 30 September 2025 | 26,641 |  |

| NET BOOK VALUE

| At 30 September 2025 | 1,779 |  |

| At 30 September 2024 | 2,895 |  |

5. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Amounts owed by group undertakings | 13,094 |  | - |  |

| Other debtors | 6,586 |  | 9,957 |  |

19,680 |  | 9,957 |  |

EUROPEAN MEDICINES LIMITED (REGISTERED NUMBER: 08067182)

NOTES TO THE FINANCIAL STATEMENTS - continued

FOR THE YEAR ENDED 30 SEPTEMBER 2025

6. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Taxation and social security | 10,359 |  | 9,748 |  |

| Other creditors | 30,224 |  | 13,251 |  |

40,583 |  | 22,999 |  |

7. | LEASING AGREEMENTS

| Minimum lease payments under non-cancellable operating leases fall due as follows:

2025 | 2024 |

£ | £ |

| Within one year | 45,913 |  | 18,598 |  |

| Between one and five years | 89,111 |  | 8,887 |  |

135,024 |  | 27,485 |  |

8. | DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

| The Report of the Auditors was unqualified.

| Douglas Paton BSc CA (Senior Statutory Auditor)

| for and on behalf of Bannerman Johnstone Maclay Limited

9. | ULTIMATE CONTROLLING PARTY

| The ultimate controlling party is Mosadex Holdings B.V.

| The registered address is De Weegschaal 14, 5215 MN 's-Hertogenbosch, Netherlands.